Pediatric Prescription-Opioid Overdose Visits to ED Increased in 2020
THURSDAY, April 18, 2024 -- There was a substantial increase in pediatric prescription-opioid overdose emergency department visits from 2019 to 2020 in the United States, according to a study published online April 17 in PLOS ONE.Audrey Lu,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2024 Category: Pharmaceuticals Source Type: news
Weight-Related Bullying Increases With More Screen Time, Social Media Use
THURSDAY, April 18, 2024 -- Among an international sample of adolescents, there is an association of increased screen time hours and social media use with weight-related bullying, according to a study published online April 17 in PLOS ONE.Kyle... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2024 Category: Pharmaceuticals Source Type: news
Ending Specialized Follow-Up Feasible in Asymptomatic, Low-Risk Leukemia
THURSDAY, April 18, 2024 -- For select patients with asymptomatic, lower-risk chronic lymphocytic leukemia, ending specialized follow-up (sFU) is feasible and safe, according to a study published in the March 1 issue of Blood Advances.Christian... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2024 Category: Pharmaceuticals Source Type: news
Lower Risk for MCI, Dementia Seen With Cognitively Stimulating Occupations
WEDNESDAY, April 17, 2024 -- Individuals with a history of cognitively stimulating occupations from ages 30 to 65 years have lower risk for mild cognitive impairment (MCI) and dementia in later life, according to a study published online April 17... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Mortality Risks Up for Women With Adverse Pregnancy Outcomes
WEDNESDAY, April 17, 2024 -- Women who experience any of five major adverse pregnancy outcomes have increased mortality risks, which remain elevated during long-term follow-up, according to a study published online April 15 in JAMA Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Seven in 10 Experiencing Homelessness Have a Mental Health Disorder
WEDNESDAY, April 17, 2024 -- The majority of people experiencing homelessness have mental health disorders, according to a review published online April 17 in JAMA Psychiatry.Rebecca Barry, Ph.D., from the Cumming School of Medicine at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Reports of Injuries, Deaths Prompt FDA to Recall Heart Failure Devices
WEDNESDAY, April 17, 2024 -- The HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories, are now under a strict U.S. Food and Drug Administration recall after being tied to 273 known injuries and 14... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Eli Lilly Says Zepbound Can Ease Obstructive Sleep Apnea
WEDNESDAY, April 17, 2024 -- Eli Lilly announced Wednesday that in two company trials, Zepbound was found to ease sleep apnea in adults with obesity.First approved to treat obesity by the U.S. Food and Drug Administration last November, the power... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing
WEDNESDAY, April 17, 2024 -- The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published online April 17 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Heritability for Autism Spectrum Disorder Varies for Males and Females
WEDNESDAY, April 17, 2024 -- Heritability for autism spectrum disorder (ASD) varies for males and females, with higher heritability seen for males than females, according to a study published online April 17 in JAMA Psychiatry.
Sven Sandin, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Rapid Transitions Seen From Neutral to Negative Emotional States in PTSD
WEDNESDAY, April 17, 2024 -- Individuals with posttraumatic stress disorder (PTSD) undergo rapid transitions between neutral and negative emotional states, which are intensified by emotional numbing symptom severity, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Study IDs Risk Factors for Extraintestinal Manifestations of IBD
WEDNESDAY, April 17, 2024 -- Certain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations (EIMs) with inflammatory bowel disease (IBD), according to a study published online March 13... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
WEDNESDAY, April 17, 2024 -- Bilateral Wilms tumors (BWTs) that increase in size during neoadjuvant chemotherapy, especially in younger patients, are most often stromal-predominant, according to a study published online March 27 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Use of CT Angiogram on the Rise for Headache, Dizziness in Emergency Department
WEDNESDAY, April 17, 2024 -- There was a 67.4 percent increase in head and neck computed tomography angiography (CTA) ordering for emergency department patients presenting for headache or dizziness from 2017 through 2021, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Subclassification Can Tailor Surveillance for Pancreatic Adenocarcinoma
WEDNESDAY, April 17, 2024 -- Subclassification of individuals at high risk for pancreatic adenocarcinoma (PC) can enable the development of surveillance approaches better tailored to risk, according to a study published online April 16 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
